Current and Future Management of Brain Metastasis

Editor(s): Kim D.G. (Seoul) 
Lunsford L.D. (Pittsburgh, Pa.) 
Table of Contents
Vol. 25, 2012
Section title: Radiosurgery
Kim DG, Lunsford LD (eds): Current and Future Management of Brain Metastasis. Prog Neurol Surg. Basel, Karger, 2012, vol 25, pp 176–189

Stereotactic Radiosurgery of Brain Metastasis from Melanoma

Marchan E.M. · Sheehan J.
Department of Neurosurgery, University of Virginia, Charlottesville, Va., USA

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Brain metastasis represents the most common intracranial neoplasm in adult patients. Melanoma is the third most frequent cancer histology and consequently comprises a significant portion of brain metastasis patients. Unlike the more frequent lung and breast cancers, melanoma represents a particularly challenging entity because of its radioresistant nature. Stereotactic radiosurgery appears to overcome the inherent radioresistance of brain metastasis from melanoma and, thereby, affords a high rate of local tumor control. Reports from leading centers indicate a favorable benefit to risk profile for radiosurgery in melanoma patients. Local tumor control after radiosurgery generally exceeds 80%, and neurological complications as a result of radiosurgery are infrequent. A higher performance status and lower intracranial tumor burden in melanoma patients at the time of radiosurgery are associated with longer survival. Radiosurgery may be used in conjunction upfront with radiotherapy, resection, and chemotherapy or as a salvage therapy in selected melanoma patients. Careful radiological and neurological follow-up is required to assess local tumor control and distant intracranial disease progression. Further clinical studies will be required to better define the role of upfront and salvage radiosurgery in selected cohorts of patients with brain metastasis from melanoma. However, it appears likely that radiosurgery will play an expanded role in the overall management of these patients.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Jemal A, Siegel R, Ward E, et al: Cancer statistics 2008. CA Cancer J Clin 2008;58:71-96
  2. Zimm S, Wampler GL, Stablein D, et al: Intracerebral metastases in solid-tumor patients: Natural history and results of treatment. Cancer 1981;48:384-394
  3. Posner JB: Neurologic Complications of Cancer. Philadelphia, Davies 1995;
  4. Sperduto PW, Chao ST, Sneed PK, Luo X, Suh J, Roberge D, Bhatt A, Jensen AW, Brown PD, Shih H, Kirkpatrick J, Schwer A, Gaspar LE, Fiveash JB, Chiang V, Knisely J, Sperduto CM, Mehta M: Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys 2010;77:655-661
  5. Nieder C, Berberich W, Schnabel K: Tumor-related prognostic factors for remission of brain metastases after radiotherapy. Int J Radiat Oncol Biol Phys 1997;39:25-30
  6. Auchter RM, Lamond JP, Alexander E, Buatti JM, Chappell R, Friedman WA, Kinsella TJ, Levin AB, Noyes WR, Schultz CJ, Loeffler JS, Mehta MP: A multi-institutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis. Int J Radiat Oncol Biol Phys 1996;35:27-35
  7. Berwick M WM: Epidemiology: Current Trends. (eds) Balch C, Houghton A, Sober A, Soong S: Cutaneous Melanoma St. Louis, Quality Medical Publishing, 2003;
  8. Harrison BE, Johnson JL, Clough RW, Halperin EC: Selection of patients with melanoma brain metastases for aggressive treatment. Am J Clin Oncol 2003;26:354-357
  9. Fife KM, Colman MH, Stevens GN, Firth IC, Moon D, Shannon KF, Harman R, Petersen-Schaefer K, Zacest AC, Besser M, Milton GW, McCarthy WH, Thompson JF: Determinants of outcome in melanoma patients with cerebral metastases. J Clin Oncol 2004;22:1293-1300
  10. Nieder C, Astner ST, Grosu AL, Andratschke NH, Molls M: The role of postoperative radiotherapy after resection of a single brain metastasis: combined analysis of 643 patients. Strahlenther Onkol 2007;183:576-580
  11. Jenrette JM: Malignant melanoma: the role of radiation therapy revisited. Semin Oncol 1996;23:759-762
  12. Skibber J, Soong S-j, Austin L, Balch C, Sawaya R: Cranial irradiation after surgical excision of brain metastases in melanoma patients. Ann Surg Oncol 1996;3:118-123
  13. Cranmer LD, Jeter JM, Morgan SS, Hersh EM, Stea B: Whole-brain radiation therapy in melanoma: an open question. Lancet Oncol 2010;11:13author reply 13-14
  14. Chang EL, Wefel JS, Hess KR, et al: Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 2009;10:1037-1044
  15. Aoyama H, Shirato H, Tago M, et al: Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 2006;295:2483-2491
  16. Aoyama H, Tago M, Kato N, Toyoda T, Kenjyo M, Hirota S, Shioura H, Inomata T, Kunieda E, Hayakawa K, Nakagawa K, Kobashi G, Shirato H: Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys 2007;68:1388-1395
  17. Clarke JW, Register S, McGregor JM, Grecula JC, Mayr NA, Wang JZ, Li K, Gupta N, Kendra KL, Olencki TE, Cavaliere R, Sarkar A, Lo SS: Stereotactic radiosurgery with or without whole brain radiotherapy for patients with a single radioresistant brain metastasis. Am J Clin Oncol 2010;33:70-74
  18. Hazard LJ, Jensen RL, Shrieve DC: Role of stereotactic radiosurgery in the treatment of brain metastases. Am J Clin Oncol 2005;28:403-410
  19. Schoggl A, Kitz K, Reddy M, et al: Defining the role of stereotactic radiosurgery versus microsurgery in the treatment of single brain metastases. Acta Neurochir (Wien) 2000;142:621-626
  20. O'Neill BP, Iturria NJ, Link MJ, et al: A comparison of surgical resection and stereotactic radiosurgery in the treatment of solitary brain metastases. Int J Radiat Oncol Biol Phys 2003;55:1169-1176
  21. Samlowski WE, Watson GA, Wang M, et al: Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS). Cancer 2007;109:1855-1862
  22. Brown PD, Brown CA, Pollock BE, et al: Stereotactic radiosurgery for patients with ‘radioresistant’ brain metastases. Neurosurgery 2002;51:656-665
  23. Chang EL, Selek U, Hassenbusch SJ, III, et al: Outcome variation among ‘radioresistant’ brain metastases treated with stereotactic radiosurgery. Neurosurgery 2005;56:936-945
  24. Selek U, Chang EL, Hassenbusch SJ, 3rd, et al: Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases. Int J Radiat Oncol Biol Phys 2004;59:1097-1106
  25. Radbill AE, Fiveash JF, Falkenberg ET, et al: Initial treatment of melanoma brain metastases using gamma knife radiosurgery: an evaluation of efficacy and toxicity. Cancer 2004;101:825-833
  26. Mingione V, Oliveira M, Prasad D, et al: Gamma surgery for melanoma metastases in the brain. J Neurosurg 2002;96:544-551
  27. Lavine SD, Petrovich Z, Cohen-Gadol AA, et al: Gamma knife radiosurgery for metastatic melanoma: an analysis of survival, outcome, and complications. Neurosurgery 1999;44:59-64discussion64-56
  28. Mathieu D, Kondziolka D, Cooper PB, et al: Gamma knife radiosurgery for malignant melanoma brain metastases. Clin Neurosurg 2007;54:241-247
  29. Manon R, O'Neill A, Knisely J, et al: Phase II trial of radiosurgery for one to three newly diagnosed brain metastases from renal cell carcinoma, melanoma, and sarcoma: an Eastern Cooperative Oncology Group study (E 6397). J Clin Oncol 2005;23:8870-8876
  30. Gaudy-Marqueste C, Regis JM, Muracciole X, et al: Gamma-Knife radiosurgery in the management of melanoma patients with brain metastases: a series of 106 patients without whole-brain radiotherapy. Int J Radiat Oncol Biol Phys 2006;65:809-816
  31. Mori Y, Kondziolka D, Flickinger JC, et al: Stereotactic radiosurgery for cerebral metastatic melanoma: factors affecting local disease control and survival. Int J Radiat Oncol Biol Phys 1998;42:581-589
  32. Gonzalez-Martinez J, Hernandez L, Zamorano L, et al: Gamma knife radiosurgery for intracranial metastatic melanoma: a 6-year experience. J Neurosurg 2002;97:494-498
  33. Filley CM, Kleinschmidt-DeMasters BK: Toxic leukoencephalopathy Ν. Engl J Med 2001;345:425-432
  34. Koc M, McGregor J; Grecula J; Bauer C, Gupta N, Gahbauer RA: Gamma Knife radiosurgery for intracranial metastatic melanoma: an analysis of survival and prognostic factors. J Neuro-Oncol 2005;71:307-313
  35. Somaza S, Kondziolka D, Lunsford LD, Kirkwood JM, Flickinger JC: Stereotactic radiosurgery for cerebral metastatic melanoma. J Neurosurg 1993;79:661-666
  36. Chang EL, Selek U, Hassenbusch III SJ, et al: Outcome variation among ‘radioresistant’ brain metastases treated with stereotactic radiosurgery. Neurosurgery 2005;56:936-945
  37. Liew DN, Kano H, Kondziolka D, Mathieu D, Niranjan A, Flickinger J, Kirkwood J, Tarhini A, Moschos S, Lunsford LD: Outcome predictors of Gamma Knife surgery for melanoma brain metastases. J Neurosurg 2011;114:769-779
  38. Noël G, Simon JM, Valery CA, Cornu P, Boisserie G, Ledu D, Hasboun D, Tep B, Delattre JY, Marsault C, Baillet F, Mazeron JJ: LINAC radiosurgery for brain metastasis of melanoma. Stereotact Funct Neurosurg 2002;79:245-255
  39. Herfarth KK, Izwekowa O, Thilmann C, Pirzkall A, Delorme S, Hofmann U, Schadendorf D, Zierhut D, Wannenmacher M, Debus J: LINAC-based radiosurgery of cerebral melanoma metastases: analysis of 122 metastases treated in 64 patients. Strahlenther Onkol 2003;179:366-371
  40. Jagannathan J, Yen CP, Ray DK, Schlesinger D, Oskouian RJ, Pouratian N, Shaffrey ME, Larner J, Sheehan JP: Gamma Knife radiosurgery to the surgical cavity following resection of brain metastases. J Neurosurg 2009;111:431-438
  41. Loeffler JS, Kooy HM, Wen PY, et al: The treatment of recurrent brain metastases with stereotactic radiosurgery. J Clin Oncol 1990;8:576-582
  42. Noel G, Proudhom MA, Valery CA, et al: Radiosurgery for the re-irradiation of brain metastasis: results in 54 patients. Radiother Oncol 2001;60:61-67
  43. Chao ST, Barnett GH, Vogelbaum MA, Angelov L, Weil RJ, Neyman G, Reuther AM, Suh JH: Salvage stereotactic radiosurgery effectively treats recurrences from whole-brain radiation therapy. Cancer 2008;113:2198-2204
  44. Carella RJ, Gelber R, Hendrickson F, Berry HC, Cooper JS: Value of radiation therapy in the management of patients with cerebral metastases from malignant melanoma: Radiation Therapy Oncology Group Brain Metastases Study I and II. Cancer 1980;45:679-683
  45. Stridsklev IC, Hagen S, Klepp O: Radiation therapy for brain metastases from malignant melanoma. Acta Radiol Oncol 1984;23:231-235
  46. Sampson JH, Carter JH, Jr, Friedman AH, Seigler HF: Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg 1998;88:11-20
  47. Ellerhorst J, Strom E, Nardone E, McCutcheon I: Whole brain irradiation for patients with metastatic melanoma: a review of 87 cases. Int J Radiat Oncol Biol Phys 2001;49:93-97
  48. Buchsbaum JC, Suh JH, Lee SY, Chidel MA, Greskovich JF, Barnett GH: Survival by radiation therapy oncology group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma: a retrospective study. Cancer 2002;94:2265-2272

Pay-per-View Options
Direct payment This item at the regular price: USD 33.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 23.00